Clinical Trial Update: A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain

View source ↗

Summary

This update reports the completion of a non-interventional observational study evaluating Targinact (oxycodone/naloxone) for chronic severe pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Targinact (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma CVA | Conditions: Chronic Severe Pain | Status: COMPLETED